Medicinal Products

Erlotinib Teva 150 mg filmom obložene tablete

Name Erlotinib Teva 150 mg filmom obložene tablete
Marketing Authorisation Number HR-H-787566877
Active Substance erlotinibum
Pharmaceutical Form filmom obložena tableta
Strength 150 mg
Packaging [MA Number for Packaging] 30 tableta u blisteru, u kutiji  [HR-H-787566877-01]
30 tableta u perforiranom blisteru, u kutiji  [HR-H-787566877-02]
Manufacturer Teva UK Ltd., East Sussex, Ujedinjeno Kraljevstvo;
Pliva Hrvatska d.o.o., Zagreb, Republika Hrvatska;
Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka;
Teva Gyogyszergyar Zrt., Debrecen, Mađarska;
Teva Operations Poland Sp. z o.o., Krakow, Poljska
Marketing Authorisation Holder Teva B.V., Swensweg 5, Haarlem, Nizozemska
Marketing Authorisation Date 13.01.2017
MA Period of Validity 13.01.2022
Classification Number UP/I-530-09/15-01/200
Registration Number 381-12-01/30-17-07
Composition jedna filmom obložena tableta sadrži 150 mg erlotiniba (u obliku erlotinibklorida)
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code L01XE03
Medicinal product marketed in the Croatia Ne
SmPC download
PL download
Public Assessment Report download
Educational materials
for healthcare professionals
Brošura za zdravstvene radnike, verzija 2
Back